Eagle Pharmaceuticals, Inc. (OTC:EGRX)目前交易价格为$0.75,市值为977万美元,该公司宣布对其于2024年10月30日签订的权利协议进行修订。 这项被称为"修订案第1号"的修订并未改变原始权利协议的核心条款,并保持其完全有效。具体的变更细节尚未披露,但据称涉及董事会关于权利协议及其下发行的权利的权利和义务。
In the race to deliver innovative new digital experiences ahead of the competition, enterprises need to embrace the growing adoption of artificial i ...
The healthcare industry thrives due to novel drug pipeline discoveries, AI integration to streamline processes and technological advancements. So, investing in undervalued healthcare stocks with ...